XML 74 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders Equity - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interests
Beginning balance at Dec. 31, 2021 $ 10,748.5 $ 3.7 $ 478.0 $ 12,014.2 $ (1,891.8) $ 144.4
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2021   368,700,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 3,355.6     3,582.8 (260.4) 33.2
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,200,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (19.2)   (19.2)      
Stock based compensation $ 31.5   $ 31.5      
The total intrinsic value of options exercised during the fiscal year 16,000,000.0   16,000,000.0      
Stock Repurchased During Period, Shares   (30,800,000)        
Stock Repurchased During Period, Value $ (1,673.2) $ 0.3 $ (506.3) (1,166.6)    
Dividends, Common Stock, Cash (227.0)     (227.0)    
Dividends for noncontrolling interests (38.0)         (38.0)
Ending balance at Dec. 31, 2022 $ 12,194.2 $ 3.4 0.0 14,203.4 (2,152.2) 139.6
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2022   339,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends per share (in usd per share) $ 0.60          
Total comprehensive income (loss) $ 1,408.5     1,164.9 197.3 46.3
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,900,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition $ (54.2)   (0.8) (53.4)    
Stock based compensation     33.0      
The total intrinsic value of options exercised during the fiscal year 33,000,000.0          
Stock Repurchased During Period, Shares (16,879,059) (16,900,000)        
Stock Repurchased During Period, Value $ (754.4) $ 0.2 (32.2) (722.0)    
Dividends, Common Stock, Cash (351.0)     (351.0)    
Noncontrolling Interest, Increase from Subsidiary Equity Issuance (43.3)   0.0     43.3
Ending balance at Dec. 31, 2023 $ 12,432.8 $ 3.2 0.0 14,241.9 (1,954.9) 142.6
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2023 324,103,141 324,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends per share (in usd per share) $ 0.85          
Excised Tax on Share Repurchases $ 6.4          
Total comprehensive income (loss) (297.6)     174.9 (494.1) 21.6
Stock Issued During Period, Shares, Restricted Stock Award, Gross   700,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition $ (10.5)   0.0 (10.5)    
Stock based compensation     31.8      
The total intrinsic value of options exercised during the fiscal year 31,800,000          
Stock Repurchased During Period, Shares (7,944,507) (7,900,000)        
Stock Repurchased During Period, Value $ (237.5) $ 0.0 (29.7)      
Dividends, Common Stock, Cash (272.4)     (272.4)    
Dividends for noncontrolling interests (31.9)         (31.9)
Ending balance at Dec. 31, 2024 $ 11,614.7 $ 3.2 $ 2.1 13,926.1 $ (2,449.0) $ 132.3
Common stock shares outstanding, ending balance (in shares) at Dec. 31, 2024 316,932,047 316,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock Repurchased and Retired During Period, Value       $ (207.8)    
Dividends per share (in usd per share) $ 0.85          
Excised Tax on Share Repurchases $ 2.1